Koninklijke Philips NVBUE:PHG -1.09%56 Days Payable is 85.66 as of Mar. 2026, which is 11% above its 10-year median of 76.92. GuruFocus rates BUE:PHG with a GF Score™ of 56/100 and a GF Value™ of ARS8,043.49 (Fairly Valued). The stock has 3 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 50.82% on this metric.
The historical rank and industry rank for Koninklijke Philips NV's Days Payable or its related term are showing as below:
BUE:PHG'
s Days Payable Range Over the Past 10 Years
Min: 65.91 Med: 76.92 Max: 106.19
Current: 69.56
During the past 13 years, Koninklijke Philips NV's highest Days Payable was 106.19. The lowest was 65.91. And the median was 76.92.
BUE:PHG's Days Payable is ranked better than 50.82% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.83
vs BUE:PHG: 69.56
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koninklijke Philips NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Days Payable distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Koninklijke Philips NV's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV (BUE:PHG) has a Days Payable of 85.66 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Koninklijke Philips NV and its competitors. This is 11% above median its historical median of 76.92. Over the past decade, Koninklijke Philips NV's Days Payable has ranged from 65.91 to 106.19. According to the industry distribution chart, Koninklijke Philips NV ranks #390 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 49.2%.
Is Koninklijke Philips NV's Days Payable too high?
Koninklijke Philips NV's current Days Payable of 85.66 is 11% above median its 10-year median of 76.92. Over the past 10 years, this metric has ranged from a low of 65.91 to a high of 106.19. The Medical Devices & Instruments industry median Days Payable is 67.83. Koninklijke Philips NV's value of 85.66 is 26.3% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #390 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #390 out of 793 companies for Days Payable. This puts Koninklijke Philips NV in the upper half of its industry. The industry median Days Payable is 67.83. Koninklijke Philips NV's value of 85.66 is 26.3% above this benchmark. Historically, Koninklijke Philips NV's own Days Payable has ranged from 65.91 to 106.19 over the past decade. While the company's 10-year median is 76.92 vs. the industry median of 67.83, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.83, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Days Payable of 85.66 is 26.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Days Payable is 85.66, which is 11% above median its own 10-year median of 76.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (BUE:PHG) is currently considered Fairly Valued. The stock's GF Value™ is ARS8,043.49, compared to a current price of ARS8,605.00 — trading 7% above its estimated fair value. The current Days Payable is 85.66, which is 11% above median its 10-year median of 76.92 and 26.3% above the Medical Devices & Instruments industry median of 67.83. Koninklijke Philips NV's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Koninklijke Philips NV (BUE:PHG), the current Days Payable is 85.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (BUE:PHG) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of ARS8,605.00 is trading 7% above its estimated GF Value™ of ARS8,043.49.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for BUE:PHG:
Days Payable: 85.66 (11% above median its 10-year median of 76.92)
GF Value™: ARS8,043.49 vs. price of ARS8,605.00 (7% above fair value)
Industry Position: 26.3% above the Medical Devices & Instruments median (#390 of 793)
No single metric tells the full story. See the BUE:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
56GF Score
Get the complete analysis for BUE:PHG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:PHG has been successfully added to your 
